Astrana Health, Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $972.5M | $965.1M | $950.5M | $956.0M | $654.8M | $620.4M | $665.2M | $478.7M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $54.2M | $61.7M | $60.2M | $62.4M | $50.7M | $43.9M | $41.6M | $37.8M |
| Operating Income | $34.3M | $28.5M | $18.4M | $19.2M | $20.3M | $20.6M | $720.0K | $28.4M |
| Operating Margin | 3.5% | 3.0% | 1.9% | 2.0% | 3.1% | 3.3% | 0.1% | 5.9% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $27.2M | $19.7M | $7.5M | $5.7M | $16.8M | $9.6M | $-1.9M | $26.8M |
| Income Tax Expense | $8.8M | $6.6M | $944.0K | $4.6M | $6.6M | $3.4M | $5.9M | $7.8M |
| Net Income | $19.7M | $14.4M | $6.0M | $373.0K | $9.4M | $6.7M | $-7.0M | $16.1M |
| Net Margin | 2.0% | 1.5% | 0.6% | 0.0% | 1.4% | 1.1% | -1.0% | 3.4% |
| EPS (Basic) | $0.40 | $0.30 | $0.12 | $0.01 | $0.19 | $0.14 | $-0.14 | $0.34 |
| EPS (Diluted) | $0.40 | $0.29 | $0.12 | $0.01 | $0.19 | $0.14 | $-0.14 | $0.33 |
| Shares Outstanding (Basic) | 49.1M | 48.9M | 49.1M | 49.2M | 49.2M | 48.5M | 47.6M | 47.7M |
| Shares Outstanding (Diluted) | 49.8M | 49.1M | 49.4M | 49.5M | 49.5M | 48.9M | 48.0M | 48.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |